TCL Archive White House Plans to Name Broder NCI Director, Overruling Wyngaarden, Who Support Rabson December 2, 1988
TCL Archive Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study December 26, 2014